Abu Dhabi: For the first time in the Cleveland Clinic global network, Cleveland Clinic Abu Dhabi, part of the M42 group, has performed a robotic mastectomy, introducing a minimally invasive surgical option for breast cancer patients in the UAE. A mastectomy, the surgical removal of breast tissue, traditionally requires larger chest incisions, leading to visible scarring, loss of sensation, and extended recovery times.
According to Emirates News Agency, the robotic mastectomy uses advanced robotic technology to make a small incision under the armpit, preserving nerves around the breast and allowing for simultaneous tissue removal and reconstruction. Dr. George Haber, CEO of Cleveland Clinic Abu Dhabi, noted that the introduction of robotic mastectomy marks a transformative step in breast cancer care. He stated that this pioneering procedure, which is the first in the global network, offers patients a minimally invasive option that not only reduces recovery time but also enhances their quality of life.
The su
rgery was led by Dr. Ahmad Matalkah from Cleveland Clinic Abu Dhabi’s Breast Surgery Programme and utilised the Da Vinci single-port robotic system, which improves patient outcomes with reduced invasiveness and faster recovery. Dr. Matalkah highlighted that robotic breast surgery offers precision, minimal scarring, and faster recovery, making it suitable for selected patients with breast cancer or those opting for risk-reducing mastectomy due to genetic factors.
Dr. Tibor G Kovacs, Staff Physician at Cleveland Clinic Abu Dhabi’s Breast Surgery Programme, explained that robotic mastectomy allows for implant-based breast reconstruction, providing both physical and emotional benefits. The nipple-sparing approach, combined with immediate reconstruction, ensures precise surgery and quicker return to daily life. The procedure remains new globally, and the Abu Dhabi surgical team underwent extensive training under the guidance of international robotic surgery experts.
However, Dr. Matalkah emphasised that not all
patients qualify for robotic mastectomy, as eligibility depends on factors such as tumour size, body size, and overall health. Each case is carefully evaluated to determine the best approach.
